Salem Abu Al-Burak

Age-related macular degeneration associated with glucagon-like peptide-1 receptor agonist use: a systematic review

Salem Abu Al-Burak, Azhar Suleiman, Vitaliy Voznyy, Mouad Elganga et autres

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for diabetes, obesity, and cardiovascular risk reduction. However, their ocular safety profile, particularly regarding age-related macular degeneration (AMD), remains uncertain. This systematic review evaluates the association between GLP-1 RA use and the …

ca (code pays fourni par la source)

Diabetic macular edema and GLP-1 receptor agonist use: a systematic review and meta-analysis

Salem Abu Al-Burak, Vitaliy Voznyy, Mouad Elganga, Chris Zajner et autres

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for type II diabetes and obesity because of their cardiometabolic benefits. However, concerns regarding potential ocular adverse effects, particularly diabetic macular edema (DME), have prompted the need to clarify their retinal safety. METHODS: …

ca (code pays fourni par la source)

Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: An updated systematic review and meta-analysis

Hamzah Saad Algodi, Salem Abu Al-Burak, Eric Zeng, Bryn Tannar et autres

Acute central serous chorioretinopathy (CSC) may resolve spontaneously, but risks progression to chronic disease with visual impairment. We performed a PRISMA-compliant meta-analysis evaluating photodynamic therapy (PDT) and anti-vascular endothelial growth factor (anti-VEGF) agents versus observation in acute CSC (<6 months), searching PubMed, …

ca (code pays fourni par la source)

Medicare Trends in Intravitreal Anti-VEGF Use

Salem Abu Al-Burak, Justin Lerann Shad, Andrew Mihalache, Sean T. Berkowitz et autres

OBJECTIVE: To characterize national trends, reimbursement patterns, and geographic variation in intravitreal anti-VEGF use among Medicare beneficiaries from 2014 to 2023. DESIGN: Retrospective cross-sectional study. PARTICIPANTS: All Medicare Part B fee-for-service beneficiaries receiving intravitreal anti-VEGF injections billed by ophthalmologists in the United …

ca, us (code pays fourni par la source)

Climate Change and the Rising Burden of Ocular Disease: Diagnostic Challenges and Emerging Solutions

Salem Abu Al-Burak, M. U. Ahmed

Climate change is an emerging public health crisis that extends beyond systemic diseases to greatly impact ocular health. Increasing ultraviolet (UV) radiation exposure, worsening air pollution, and the accumulation of environmental toxins are contributing to a rise in cataracts, dry eye syndrome …